RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Craniocerebral Trauma
Accession: DOID:9007621
browse the term
Definition: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.
Synonyms: exact_synonym: Craniocerebral Injuries; Craniocerebral Injury; Craniocerebral Traumas; Crushing Skull Injuries; Crushing Skull Injury; Forehead Trauma; Forehead Traumas; Frontal Region Trauma; Frontal Region Traumas; Head Injuries; Head Injury; Head Trauma; Head Traumas; Minor Head Injuries; Minor Head Injury; Multiple Head Injuries; Multiple Head Injury; Occipital Region Trauma; Occipital Region Traumas; Occipital Trauma; Occipital Traumas; Open Head Injuries; Open Head Injury; Parietal Region Trauma; Parietal Region Traumas; Superficial Head Injuries; Superficial Head Injury; Temporal Region Trauma; Temporal Region Traumas
primary_id: MESH:D006259 ; RDO:0005059
xref: EFO:0009505
G
Adnp
activity-dependent neuroprotective protein
IDA
RGD
PMID:11123362
RGD:2312784
NCBI chr 2:168,022,885...168,049,032
Ensembl chr 2:168,022,906...168,049,032
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:microglial cell
RGD
PMID:7830934
RGD:10045949
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Postn
periostin, osteoblast specific factor
ISO
RGD
PMID:17878602
RGD:10041014
NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8810955
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23415790
RGD:10401075
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12503044
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Kcnn4
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
treatment
ISO
RGD
PMID:15379997
RGD:329969897
NCBI chr 7:24,069,750...24,084,635
Ensembl chr 7:24,069,688...24,086,115
G
Cfl1
cofilin 1, non-muscle
treatment
ISO
RGD
PMID:25708984
RGD:12738361
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Drd2
dopamine receptor D2
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Drd3
dopamine receptor D3
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Drd4
dopamine receptor D4
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Il6
interleukin 6
treatment
ISO
RGD
PMID:27113205
RGD:11062140
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
C3
complement component 3
ameliorates
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Il1b
interleukin 1 beta
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Pycard
PYD and CARD domain containing
treatment
ISO
RGD
PMID:19401709
RGD:5491174
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Abcc8
ATP-binding cassette, sub-family C member 8
treatment
ISO
RGD
PMID:21107131
RGD:12791995
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
G
Acan
aggrecan
ISO
mRNA:increased expression:fascia dentata (rat)
RGD
PMID:18511192
RGD:2315807
NCBI chr 7:78,702,974...78,764,847
Ensembl chr 7:78,703,231...78,764,847
G
Actr2
actin related protein 2
ISO
mRNA, protein:decreased expression:hippocampus (rat)
RGD
PMID:22120305
RGD:11530046
NCBI chr11:20,012,304...20,062,951
Ensembl chr11:20,012,304...20,062,913
G
Adcyap1
adenylate cyclase activating polypeptide 1
ISO
RGD
PMID:16689670
RGD:2325298
NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
G
Adra1a
adrenergic receptor, alpha 1a
ISO
mRNA:increased expression:frontal cortex
RGD
PMID:20974230
RGD:5688366
NCBI chr14:66,872,705...67,009,549
Ensembl chr14:66,872,700...67,008,617
G
Ager
advanced glycosylation end product-specific receptor
IMP ISO
protein:increased expression:brain (rat)
RGD
PMID:22915134 PMID:24859607 PMID:22491548
RGD:7245513 , RGD:8696001 , RGD:7245557
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Aif1
allograft inflammatory factor 1
ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:19520144
RGD:2313020
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Aifm1
apoptosis-inducing factor, mitochondrion-associated 1
ISO
protein:increased expression:nucleus:
RGD
PMID:12091479
RGD:10053567
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
G
Akt1
thymoma viral proto-oncogene 1
ISO
protein:increased phosphorylation:brain, neuron
RGD
PMID:16234845
RGD:5509090
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7909931 PMID:17188501
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Ambp
alpha 1 microglobulin/bikunin precursor
ISO
protein:increased expression:urine
RGD
PMID:14592616
RGD:6904155
NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
G
Ank3
ankyrin 3, epithelial
ISO
RGD
PMID:20557305
RGD:6767288
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
ISO
RGD
PMID:24385964
RGD:10401136
NCBI chr 9:62,248,637...62,286,084
Ensembl chr 9:62,248,575...62,286,094
G
Apaf1
apoptotic peptidase activating factor 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:11567033
RGD:2325751
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
G
Apbb1
amyloid beta precursor protein binding family B member 1
ISO
mRNA:increased expression:brain
RGD
PMID:12707777
RGD:2301208
NCBI chr 7:105,207,691...105,231,151
Ensembl chr 7:105,207,690...105,230,860
G
Apex1
apurinic/apyrimidinic endonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11447995
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
G
Apod
apolipoprotein D
ISO
mRNA, protein:increased expression:cerebral cortex, glia cell, neuron
RGD
PMID:10501208
RGD:2311202
NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626
G
Apoe
apolipoprotein E
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
App
amyloid beta precursor protein
ISO
protein:increased expression:hippocampus
RGD
PMID:16300758
RGD:10054281
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Aqp4
aquaporin 4
ISO IMP
protein:increased expression:cerebral cortex
RGD
PMID:21083433 PMID:21488209
RGD:5148014 , RGD:5148034
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Asic1
acid-sensing ion channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21307247
NCBI chr15:99,568,090...99,599,011
Ensembl chr15:99,568,249...99,599,011
G
Astn1
astrotactin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr 1:158,189,647...158,519,351
Ensembl chr 1:158,189,843...158,519,351
G
Atg12
autophagy related 12
ISO
protein:altered localization:brain
RGD
PMID:18059433
RGD:2301217
NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
G
Atp5pd
ATP synthase peripheral stalk subunit d
treatment
ISO
RGD
PMID:26813465
RGD:13800884
NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788
G
Avpr1a
arginine vasopressin receptor 1A
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:17244947
RGD:2300372
NCBI chr10:122,284,404...122,289,358
Ensembl chr10:122,284,404...122,289,357
G
Bad
BCL2-associated agonist of cell death
ISO
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:15941375
RGD:2292694
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcat1
branched chain aminotransferase 1, cytosolic
ISO
Protein:increased expression:neurons
RGD
PMID:10686349
RGD:631308
NCBI chr 6:144,939,561...145,021,883
Ensembl chr 6:144,939,561...145,021,910
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:18093155 PMID:20888848
RGD:2293059 , RGD:10054247
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bdnf
brain derived neurotrophic factor
IEP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15500971 PMID:21269288 PMID:20544832
RGD:4891136
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Becn1
beclin 1, autophagy related
ISO IEP
protein:increased expression:neuron, astrocyte CTD Direct Evidence: therapeutic protein:increased expression:hippocampus protein:increased expression:brain
CTD RGD
PMID:34929507 PMID:18500386 PMID:24221859 PMID:16874043
RGD:6483098 , RGD:11558018 , RGD:6483314
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Birc5
baculoviral IAP repeat-containing 5
ISO
mRNA, protein:increased expression:brain, astrocyte, neuron
RGD
PMID:15453988
RGD:2293136
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Bmp6
bone morphogenetic protein 6
ISO
protein:increased expression:brain, astrocyte, neuron
RGD
PMID:16388909
RGD:2289020
NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278
G
Bmpr2
bone morphogenetic protein receptor type 2
ISO
mRNA:increased expression:dentate gyrus, neuron
RGD
PMID:9080432
RGD:5129488
NCBI chr 1:59,802,721...59,917,240
Ensembl chr 1:59,802,559...59,918,173
G
Bysl
bystin-like
ISO
mRNA, protein:increased expression:substantia nigra, striatum (rat)
RGD
PMID:15305856
RGD:2316201
NCBI chr17:47,910,256...47,922,417
Ensembl chr17:47,910,256...47,922,417
G
C1qa
complement component 1, q subcomponent, alpha polypeptide
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
G
C3
complement component 3
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr X:13,383,319...13,713,020
Ensembl chr X:13,383,319...13,717,606
G
Casp1
caspase 1
ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500
RGD:2315917
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp12
caspase 12
severity
ISO
mRNA, protein:increased expression, increased activity:cerebral cortex, hippocampus, neuron, astrocyte
RGD
PMID:14675152
RGD:2311485
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
ISO
protein:altered localization
RGD
PMID:15590916
RGD:1624191
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cast
calpastatin
severity
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:15307896
RGD:5509821
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
protein:increased expression:brain, neuron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:19210118 PMID:11113322
RGD:2306999 , RGD:9587789
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:22040257
RGD:7483630
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
Ccr5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:hippocampus
RGD
PMID:24344922
RGD:8552265
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd14
CD14 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd40
CD40 antigen
treatment
ISO
RGD
PMID:23924471
RGD:7248749
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
treatment
ISO
RGD
PMID:11755016 PMID:25972624
RGD:8547803 , RGD:11344972
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:nucleus:
RGD
PMID:9914434
RGD:8662346
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cebpa
CCAAT/enhancer binding protein alpha
IEP
mRNA, protein:increased expression:cerebral cortex (mouse)
RGD
PMID:19833158
RGD:10401206
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
Cebpb
CCAAT/enhancer binding protein beta
IEP ISO
mRNA, protein:increased expression:cerebral cortex (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:19833158
RGD:10401206
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Ces1d
carboxylesterase 1D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
G
Cfb
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17474994
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Chrm2
cholinergic receptor, muscarinic 2, cardiac
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
G
Chrna7
cholinergic receptor, nicotinic, alpha polypeptide 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317
G
Ckmt1
creatine kinase, mitochondrial 1, ubiquitous
treatment
ISO
RGD
PMID:24252176
RGD:11565089
NCBI chr 2:121,188,257...121,194,218
Ensembl chr 2:121,188,195...121,194,218
G
Clec4e
C-type lectin domain family 4, member e
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 6:123,258,748...123,266,830
Ensembl chr 6:123,258,748...123,266,829
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:increased expression:hippocampus
RGD
PMID:20215974
RGD:6483336
NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555
G
Comt
catechol-O-methyltransferase
ISO
protein:increased expression:hippocampus
RGD
PMID:17240060
RGD:2289740
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Crp
C-reactive protein, pentraxin-related
disease_progression
ISO
RGD
PMID:24456846
RGD:9585646
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
disease_progression
ISO
RGD
PMID:21515263
RGD:5686795
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:24239694
RGD:11039431
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cspg4
chondroitin sulfate proteoglycan 4
ISO
protein:altered expression:cerebral cortex
RGD
PMID:19473238
RGD:5686860
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
G
Cul5
cullin 5
ISO
mRNA, protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17010517
RGD:2301432
NCBI chr 9:53,525,881...53,578,807
Ensembl chr 9:53,525,882...53,581,314
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
mRNA:increased expression:choroid plexus, cerebral cortex
RGD
PMID:19471279
RGD:5135009
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
protein:increased expression:brain, neuron
RGD
PMID:19210118
RGD:2306999
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
ISO
mRNA:increased expression:hindbrain
RGD
PMID:16329132
RGD:1599699
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
G
Cyp4f14
cytochrome P450, family 4, subfamily f, polypeptide 14
ISO
RGD
PMID:18847377
RGD:2301705
NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
G
Dab2
disabled 2, mitogen-responsive phosphoprotein
ISO
RGD
PMID:15774263
RGD:7243841
NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193
G
Dnmt1
DNA methyltransferase 1
ISO
RGD
PMID:19429151
RGD:9588608
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dpysl2
dihydropyrimidinase-like 2
ISO
protein:increased degradation:cerebral cortex, hippocampus
RGD
PMID:17402852
RGD:2303056
NCBI chr14:67,040,313...67,148,490
Ensembl chr14:67,040,313...67,148,410
G
Drd2
dopamine receptor D2
ISO
RGD
PMID:18509630
RGD:2311580
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Dusp5
dual specificity phosphatase 5
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:12503083
RGD:2317873
NCBI chr19:53,517,576...53,530,240
Ensembl chr19:53,517,540...53,530,862
G
Eif2s1
eukaryotic translation initiation factor 2, subunit 1 alpha
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
G
Eif3e
eukaryotic translation initiation factor 3, subunit E
treatment
ISO
RGD
PMID:22960363
RGD:10395371
NCBI chr15:43,113,436...43,146,132
Ensembl chr15:43,113,454...43,146,115
G
Elk1
ELK1, member of ETS oncogene family
ISO
RGD
PMID:15362724
RGD:7488910
NCBI chr X:20,799,634...20,816,847
Ensembl chr X:20,799,634...20,816,847
G
Eno2
enolase 2, gamma neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34533065
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
G
Epas1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:22960363
RGD:10395371
NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
G
Epha4
Eph receptor A4
ISO
protein:increased expression, increased activity:astrocyte
RGD
PMID:22318127
RGD:5688763
NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725
G
Ephx2
epoxide hydrolase 2, cytoplasmic
IMP
RGD
PMID:21075124
RGD:5688356
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Epo
erythropoietin
treatment
ISO
CTD Direct Evidence: therapeutic mRNA:increased expression:brain:
CTD RGD
PMID:20833152 PMID:23063952 PMID:18093155
RGD:10401061 , RGD:2293059
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Epor
erythropoietin receptor
ISO
mRNA:increased expression:brain:
RGD
PMID:18093155
RGD:2293059
NCBI chr 9:21,870,193...21,874,915
Ensembl chr 9:21,870,193...21,874,802
G
F2
coagulation factor II
severity
ISO
RGD
PMID:21355766
RGD:5147766
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
Fas
Fas cell surface death receptor
ISO IMP
mRNA:increased expression:hippocampus associated with Hyperoxia
RGD
PMID:16078565 PMID:19107989
RGD:1600354 , RGD:8662854
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21269288
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fmr1
fragile X messenger ribonucleoprotein 1
ISO
protein:altered localization:hippocampus (rat)
RGD
PMID:16510718
RGD:11667962
NCBI chr X:67,722,144...67,761,569
Ensembl chr X:67,722,147...67,761,569
G
Fos
FBJ osteosarcoma oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9630518
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxp1
forkhead box P1
treatment
ISO
RGD
PMID:26842647
RGD:11561903
NCBI chr 6:98,902,303...99,510,587
Ensembl chr 6:98,902,299...99,499,682
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
ISO
protein:decreased expression:hippocampus
RGD
PMID:18501200
RGD:2307353
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gabrb3
GABRB3, gamma-aminobutyric acid type A receptor subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:57,240,266...57,478,550
Ensembl chr 7:57,069,440...57,478,550
G
Gabrg3
gamma-aminobutyric acid type A receptor, subunit gamma 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:56,366,211...57,037,173
Ensembl chr 7:56,366,213...57,036,936
G
Gdnf
glial cell line derived neurotrophic factor
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gja1
gap junction protein, alpha 1
treatment
ISO
RGD
PMID:23485053
RGD:8662424
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Gja5
gap junction protein, alpha 5
ISO
protein:increased expression:cerebral artery
RGD
PMID:21895483
RGD:7207391
NCBI chr 3:96,939,718...96,960,950
Ensembl chr 3:96,812,009...96,984,732
G
Gpx1
glutathione peroxidase 1
ISO
mRNA:decreased expression:hippocampus, neuron
RGD
PMID:15791111
RGD:2306624
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Grm8
glutamate receptor, metabotropic 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24675465 PMID:22643085
RGD:10045646
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsn
gelsolin
ISO
RGD
PMID:14588109
RGD:1599864
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Hcn1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:11726545
RGD:9686434
NCBI chr13:117,738,856...118,117,564
Ensembl chr13:117,738,856...118,123,954
G
Hmgb1
high mobility group box 1
treatment
ISO
RGD
PMID:22915134
RGD:7245513
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
ISO
RGD
PMID:18562561
RGD:5508455
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:23470432
RGD:10755702
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
ISO
mRNA:increased expression:liver
RGD
PMID:23172820
RGD:11041806
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hspa1a
heat shock protein 1A
IEP ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:21549006
RGD:5147593
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa4
heat shock protein 4
ISO
protein:increased expression:cerebral white matter (rat)
RGD
PMID:22067617
RGD:5688785
NCBI chr11:53,150,641...53,191,306
Ensembl chr11:53,150,641...53,191,284
G
Hspb1
heat shock protein 1
ISO
RGD
PMID:11746764
RGD:6480530
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Htr7
5-hydroxytryptamine (serotonin) receptor 7
ISO
RGD
PMID:22465320
RGD:6482178
NCBI chr19:35,935,815...36,035,533
Ensembl chr19:35,936,134...36,034,907
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:brain:
RGD
PMID:16230799
RGD:11522716
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifnl2
interferon lambda 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:28,208,209...28,209,957
Ensembl chr 7:28,208,261...28,209,880
G
Igf1
insulin-like growth factor 1
treatment
ISO
human protein in a rat model
RGD
PMID:9344566
RGD:12904928
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf2
insulin-like growth factor 2
ISO
mRNA:decreased expression:brain
RGD
PMID:11123717
RGD:5509972
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Il10
interleukin 10
severity treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:23075771 PMID:23971414
RGD:7364822 , RGD:7364983
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12rb2
interleukin 12 receptor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 6:67,263,914...67,353,277
Ensembl chr 6:67,268,302...67,353,172
G
Il13ra2
interleukin 13 receptor, alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr X:146,166,474...146,214,982
Ensembl chr X:146,166,472...146,212,188
G
Il16
interleukin 16
ISO
RGD
PMID:17983426
RGD:5024939
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
G
Il17rd
interleukin 17 receptor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr14:26,760,990...26,829,243
Ensembl chr14:26,760,898...26,829,243
G
Il18
interleukin 18
severity
IAGP ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500 PMID:17188500
RGD:2315917 , RGD:2315917
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18r1
interleukin 18 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014
G
Il1a
interleukin 1 alpha
ISO
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:16024175
RGD:2311098
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism protein:increased expression:brain, cerebrospinal fluid mRNA, protein:increased expression:brain
CTD RGD
PMID:19800810 PMID:21549006 PMID:16024175 PMID:22503903 PMID:17612572
RGD:2311098 , RGD:6482651 , RGD:1626652
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1r1
interleukin 1 receptor, type I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25665855
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il3
interleukin 3
disease_progression
ISO
protein: increased expression: brain: microdialysis perfusate
RGD
PMID:21515263 PMID:20717122
RGD:5686795 , RGD:5686886
NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
G
Il31ra
interleukin 31 receptor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr13:112,649,439...112,717,266
Ensembl chr13:112,656,432...112,730,894
G
Il4
interleukin 4
ISO
protein:decreased expression:plasma
RGD
PMID:24519543
RGD:10402802
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il5
interleukin 5
treatment
ISO
RGD
PMID:24602693 PMID:24530657
RGD:11522766 , RGD:11522770
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Il6
interleukin 6
ISO
protein:increased expression:cerebrospinal fluid (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19800810 PMID:21549006 PMID:23159883 PMID:10027774
RGD:11049549
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
G
Il9r
interleukin 9 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr11:32,137,544...32,155,283
Ensembl chr11:32,137,541...32,150,279
G
Irf1
interferon regulatory factor 1
ISO
mRNA:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:12503083
RGD:2317873
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
G
Jak2
Janus kinase 2
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jun
jun proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
ISO
RGD
PMID:20861444
RGD:8662901
NCBI chr 1:172,168,777...172,201,652
Ensembl chr 1:172,168,777...172,201,652
G
Kdr
kinase insert domain protein receptor
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21307798 PMID:19733172
RGD:5684382 , RGD:5684402
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Lep
leptin
ISO
RGD
PMID:21276361
RGD:5128517
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lsg1
large 60S subunit nuclear export GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr16:30,380,187...30,406,430
Ensembl chr16:30,379,312...30,406,410
G
Ly86
lymphocyte antigen 86
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr13:37,529,276...37,603,012
Ensembl chr13:37,529,184...37,603,012
G
Mag
myelin-associated glycoprotein
susceptibility
ISO
RGD
PMID:17156367
RGD:9685230
NCBI chr 7:30,598,600...30,614,347
Ensembl chr 7:30,598,601...30,614,298
G
Map1b
microtubule-associated protein 1B
ISO
protein:increased expression, increased phosphorylation:brain
RGD
PMID:10906717
RGD:2304029
NCBI chr13:99,557,972...99,653,110
Ensembl chr13:99,557,954...99,653,048
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
ISO
RGD
PMID:24221859
RGD:11558018
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map2
microtubule-associated protein 2
ISO
protein:decreased expression:cerebral cortex, neuron
RGD
PMID:21401443 PMID:20568963
RGD:6483087 , RGD:6483089
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO IEP
associated with Subarachnoid Hemorrhage
RGD
PMID:27000704 PMID:33414375 PMID:26100626
RGD:155791672 , RGD:155882440 , RGD:155804286
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mbl2
mannose-binding lectin (protein C) 2
disease_progression
IMP
RGD
PMID:18183030
RGD:12910935
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mbp
myelin basic protein
ISO
RGD
PMID:18583256
RGD:7349333
NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762
G
Mdm2
transformed mouse 3T3 cell double minute 2
ISO
protein:increased expression:brain cortex (rat)
RGD
PMID:15165363
RGD:2317397
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
RGD
PMID:15922484
RGD:1641989
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir132
microRNA 132
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr11:75,064,508...75,064,573
Ensembl chr11:75,064,508...75,064,573
G
Mir144
microRNA 144
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr11:77,963,831...77,963,896
Ensembl chr11:77,963,831...77,963,896
G
Mir153
microRNA 153
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr12:117,214,437...117,214,505
Ensembl chr12:117,214,437...117,214,505
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 6:30,169,667...30,169,736
Ensembl chr 6:30,169,667...30,169,736
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19631748 PMID:16671440 PMID:24661104
RGD:1582656 , RGD:13207312
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
mt-Co2
cytochrome c oxidase II, mitochondrial
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:11686499
RGD:2302298
NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
G
Mt2
metallothionein 2
IEP ISO
mRNA:increased expression:liver (mouse) mRNA:increased expression:dentate gyrus (rat)
RGD
PMID:22363575 PMID:15650329
RGD:6483812 , RGD:6483847
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mt3
metallothionein 3
treatment
ISO
RGD
PMID:16314047 PMID:10595827 PMID:10218634
RGD:6480628 , RGD:9685805 , RGD:9685803
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Myoc
myocilin
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12799138
RGD:7401267
NCBI chr 1:162,466,719...162,477,263
Ensembl chr 1:162,466,724...162,477,262
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
protein:increased expression:lung:
RGD
PMID:18787991 PMID:25089700
RGD:5134971 , RGD:11576302
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Ngb
neuroglobin
severity
ISO
RGD
PMID:21915648
RGD:9743963
NCBI chr12:87,144,305...87,149,313
Ensembl chr12:87,144,305...87,149,313
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
treatment
ISO
RGD
PMID:23940017
RGD:10414074
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Nos2
nitric oxide synthase 2, inducible
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nox4
NADPH oxidase 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36762617
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
G
Nppb
natriuretic peptide type B
ISO
associated with lung diseases;protein:increased expression:serum: CTD Direct Evidence: therapeutic
CTD RGD
PMID:19803787 PMID:23837838
RGD:7247620
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Npy
neuropeptide Y
ISO
protein:increased expression:adrenal medulla
RGD
PMID:23570732
RGD:10448961
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
mRNA:increased expression:lung associated with Subarachnoid Hemorrhage
RGD
PMID:18787991 PMID:20864352
RGD:5134971 , RGD:11035222
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nt5e
5' nucleotidase, ecto
ISO
protein:altered expression:cerebral cortex (rat)
RGD
PMID:21337375
RGD:5134348
NCBI chr 9:88,209,662...88,254,142
Ensembl chr 9:88,209,250...88,254,145
G
P2ry1
purinergic receptor P2Y, G-protein coupled 1
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:19115395
RGD:2315811
NCBI chr 3:60,910,206...60,916,403
Ensembl chr 3:60,910,216...60,916,403
G
Palld
palladin, cytoskeletal associated protein
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:12932445
RGD:2325786
NCBI chr 8:61,964,465...62,355,741
Ensembl chr 8:61,964,467...62,355,724
G
Parp1
poly (ADP-ribose) polymerase family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17640816
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pawr
PRKC, apoptosis, WT1, regulator
ISO
mRNA,protein:increased expression:brain:
RGD
PMID:11421591
RGD:9835358
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pde4d
phosphodiesterase 4D, cAMP specific
ISO
mRNA, protein:alternative form, decreased phosphorylation:brain
RGD
PMID:23057870
RGD:7327147
NCBI chr13:108,790,711...110,092,503
Ensembl chr13:108,586,482...110,089,995
G
Pdgfa
platelet derived growth factor, alpha
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pecam1
platelet/endothelial cell adhesion molecule 1
ISO
RGD
PMID:22658532
RGD:6484732
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pglyrp1
peptidoglycan recognition protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 7:18,618,615...18,624,363
Ensembl chr 7:18,605,256...18,624,384
G
Pgr
progesterone receptor
ISO
RGD
PMID:23211561
RGD:7248711
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
G
Phb1
prohibitin 1
ISO
protein:increased oxidation:cerebral cortex
RGD
PMID:17518533
RGD:2292409
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
Phb2
prohibitin 2
ISO
RGD
PMID:24566151
RGD:12903261
NCBI chr 6:124,689,252...124,693,908
Ensembl chr 6:124,689,299...124,693,913
G
Pias1
protein inhibitor of activated STAT 1
ISO
protein:decreased expression:brain, nucleus
RGD
PMID:21545521
RGD:8693413
NCBI chr 9:62,785,648...62,888,161
Ensembl chr 9:62,785,650...62,895,206
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
agonist more effective in combination with simvastatin (rat)
RGD
PMID:18562561
RGD:5508455
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
treatment
IEP ISO
protein:decreased expression:frontal cortex (rat)
RGD
PMID:22642418 PMID:24345766
RGD:6484257 , RGD:10059630
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ppp3ca
protein phosphatase 3, catalytic subunit, alpha isoform
ISO
protein: :hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14499481 PMID:19751097
RGD:6483311
NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488
G
Prf1
perforin 1 (pore forming protein)
ISO
RGD
PMID:20537642
RGD:6482807
NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
G
Ptger3
prostaglandin E receptor 3 (subtype EP3)
ISO
protein:increased expression:striatum, microglia (rat)
RGD
PMID:15234107
RGD:9850280
NCBI chr 3:157,272,459...157,350,392
Ensembl chr 3:157,272,529...157,351,525
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IMP ISO
protein:increased expression:microglia, macrophage protein:increased expression:microglial cells, macrophage, endothelial cell
RGD
PMID:19719848 PMID:11565600 PMID:12005397
RGD:5688162 , RGD:5688242 , RGD:5688239
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12410334 PMID:20810888 PMID:21549006 PMID:21866634 PMID:19719848
RGD:5508191 , RGD:5688162
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptprz1
protein tyrosine phosphatase receptor type Z, polypeptide 1
ISO
RGD
PMID:12088737
RGD:727637
NCBI chr 6:22,875,302...23,052,915
Ensembl chr 6:22,875,501...23,052,915
G
Rchy1
ring finger and CHY zinc finger domain containing 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr 5:92,096,701...92,110,988
Ensembl chr 5:92,096,763...92,110,927
G
Reg3b
regenerating islet-derived 3 beta
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:19351265
RGD:9831399
NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
protein:increased expression:ileum
RGD
PMID:18288455
RGD:2298787
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Ret
ret proto-oncogene
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Rhoa
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17929039
RGD:2298888
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Robo1
roundabout guidance receptor 1
ISO
mRNA:increased expression:brain protein:increased expression:brain, immune cell
RGD
PMID:16262652 PMID:26550694
RGD:2316136 , RGD:243048437
NCBI chr16:71,824,406...72,844,379
Ensembl chr16:72,105,194...72,842,983
G
Robo2
roundabout guidance receptor 2
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...74,889,765
G
Robo3
roundabout guidance receptor 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 9:37,327,341...37,344,730
Ensembl chr 9:37,326,965...37,344,542
G
Rps27a
ribosomal protein S27A
ISO
mRNA:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17936732
RGD:11041870
NCBI chr11:29,495,842...29,498,040
Ensembl chr11:29,495,846...29,498,109
G
S100b
S100 protein, beta polypeptide, neural
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:11520488 PMID:21783483 PMID:21976236
RGD:5508761
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Sele
selectin, endothelial cell
ISO
protein:increased expression:brain
RGD
PMID:19107536
RGD:2313599
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21534203
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
treatment
ISO
human gene in a rat model protein:altered expression:cerebellum (rat)
RGD
PMID:20142768 PMID:17709187
RGD:8612994 , RGD:8622925
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Sirt1
sirtuin 1
treatment
ISO
RGD
PMID:17970622
RGD:9497541
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Skp2
S-phase kinase-associated protein 2
ISO
protein:increased expression:brain
RGD
PMID:19852587
RGD:2315049
NCBI chr15:9,112,070...9,155,512
Ensembl chr15:9,112,073...9,155,512
G
Slc18a3
solute carrier family 18 (vesicular monoamine), member 3
ISO
protein:decreased expression:brain
RGD
PMID:18848922
RGD:5686682
NCBI chr14:32,184,394...32,186,807
Ensembl chr14:32,184,395...32,186,807
G
Slit1
slit guidance ligand 1
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr19:41,586,263...41,735,714
Ensembl chr19:41,588,696...41,732,104
G
Slit2
slit guidance ligand 2
exacerbates
ISO
RGD
PMID:26550694
RGD:243048437
NCBI chr 5:48,138,633...48,465,077
Ensembl chr 5:48,140,480...48,465,075
G
Slit3
slit guidance ligand 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr11:35,012,283...35,599,334
Ensembl chr11:35,012,051...35,599,334
G
Snca
synuclein, alpha
IEP ISO
RGD
PMID:14637093 PMID:25089700
RGD:6480195 , RGD:11576302
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Sncb
synuclein, beta
IEP
RGD
PMID:14637093
RGD:6480195
NCBI chr13:54,906,673...54,914,435
Ensembl chr13:54,906,673...54,914,408
G
Sncg
synuclein, gamma
IEP
RGD
PMID:14637093
RGD:6480195
NCBI chr14:34,092,231...34,096,626
Ensembl chr14:34,092,231...34,096,746
G
Snw1
SNW domain containing 1
ISO
mRNA, protein:increased expression:cerebral cortex (rat)
RGD
PMID:22965216
RGD:11035237
NCBI chr12:87,496,680...87,519,069
Ensembl chr12:87,495,845...87,519,044
G
Sod1
superoxide dismutase 1, soluble
IDA
RGD
PMID:16248885
RGD:1581214
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:24462953 PMID:16248885
RGD:1581214
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
mRNA:increased expression:brain, blood vessel
RGD
PMID:9704602
RGD:2300066
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Sstr2
somatostatin receptor 2
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr11:113,510,153...113,516,854
Ensembl chr11:113,510,168...113,516,854
G
Sstr3
somatostatin receptor 3
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr15:78,421,214...78,433,565
Ensembl chr15:78,421,208...78,428,885
G
Sstr4
somatostatin receptor 4
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr 2:148,237,297...148,238,684
Ensembl chr 2:148,237,264...148,238,687
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat3
signal transducer and activator of transcription 3
ISO
protein:increased phosphorylation:brain
RGD
PMID:21596098 PMID:22145815 PMID:22827467
RGD:6483023 , RGD:8694312 , RGD:6892706
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Strn
striatin, calmodulin binding protein
ISO
RGD
PMID:16351572
RGD:2311293
NCBI chr17:78,957,327...79,043,990
Ensembl chr17:78,957,342...79,044,625
G
Tardbp
TAR DNA binding protein
ISO
RGD
PMID:22101322
RGD:5687195
NCBI chr 4:148,696,839...148,711,672
Ensembl chr 4:148,696,839...148,711,476
G
Th
tyrosine hydroxylase
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:21047500
RGD:5128822
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Thbd
thrombomodulin
onset
ISO
RGD
PMID:17895610
RGD:5685007
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Ticam2
TIR domain containing adaptor molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr18:46,691,298...46,707,600
Ensembl chr18:46,690,358...46,707,600
G
Timp1
tissue inhibitor of metalloproteinase 1
ISO
mRNA:increased expression:brain, astrocytes
RGD
PMID:10719361
RGD:2290468
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp2
tissue inhibitor of metalloproteinase 2
ISO
mRNA:increased expression:brain, neuron, microglial cell
RGD
PMID:10719361
RGD:2290468
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tjp1
tight junction protein 1
ISO
RGD
PMID:19889224
RGD:2325128
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
G
Tlr1
toll-like receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 5:65,082,023...65,090,945
Ensembl chr 5:65,082,022...65,090,906
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:18316784
RGD:2312713
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:18316784
RGD:2312713
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr9
toll-like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19800810 PMID:21549006 PMID:10674461
RGD:13825262
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf13b
tumor necrosis factor receptor superfamily, member 13b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr11:61,017,567...61,040,435
Ensembl chr11:61,017,581...61,040,198
G
Tnfrsf13c
tumor necrosis factor receptor superfamily, member 13c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr15:82,105,943...82,108,581
Ensembl chr15:82,105,944...82,108,570
G
Tnfrsf14
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 4:155,002,944...155,013,077
Ensembl chr 4:155,006,390...155,013,020
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:17074049
RGD:1624183
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf26
tumor necrosis factor receptor superfamily, member 26
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:143,161,422...143,181,690
Ensembl chr 7:143,161,396...143,182,459
G
Tnfsf10
tumor necrosis factor (ligand) superfamily, member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
G
Tnfsf12
tumor necrosis factor (ligand) superfamily, member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr11:69,577,066...69,586,924
Ensembl chr11:69,577,076...69,586,675
G
Traf4
TNF receptor associated factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr11:78,049,249...78,056,405
Ensembl chr11:78,049,325...78,056,415
G
Trf
transferrin
ISO
RGD
PMID:22538758
RGD:7244386
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
ISO
mRNA, protein:increased expression:cerebral cortex, hippocampus
RGD
PMID:20309649
RGD:9999437
NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
ISO
mRNA:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:17936732
RGD:11041870
NCBI chr 8:70,960,913...70,963,067
Ensembl chr 8:70,960,913...70,963,451
G
Ucp2
uncoupling protein 2 (mitochondrial, proton carrier)
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12858170 PMID:12858170
RGD:7204436
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:18065154 PMID:12230324
RGD:1580574
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vegfb
vascular endothelial growth factor B
ISO
mRNA, protein:increased expression:brain
RGD
PMID:12230324
RGD:1580574
NCBI chr19:6,959,840...6,965,019
Ensembl chr19:6,959,841...6,965,019
G
Vim
vimentin
IEP ISO
protein:increased expression:brain
RGD
PMID:19728994 PMID:15527750
RGD:6480519 , RGD:6480527
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Xdh
xanthine dehydrogenase
treatment
ISO
RGD
PMID:26528358
RGD:13208950
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:polymorphism:exon:
RGD
PMID:9214529
RGD:7495763
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Tardbp
TAR DNA binding protein
ISO
protein:increased expression:brain
RGD
PMID:20720505
RGD:5687179
NCBI chr 4:148,696,839...148,711,672
Ensembl chr 4:148,696,839...148,711,476
G
Becn1
beclin 1, autophagy related
IEP
protein:increased expression:neuron
RGD
PMID:16004578
RGD:6483315
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Gfap
glial fibrillary acidic protein
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
ISO
human protein in a rat model
RGD
PMID:17014847
RGD:13504858
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Igf1
insulin-like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Vim
vimentin
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Aldh3a1
aldehyde dehydrogenase family 3, subfamily A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28038895
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
G
Trp63
transformation related protein 63
IEP
RGD
PMID:12167247
RGD:11568649
NCBI chr16:25,502,513...25,710,842
Ensembl chr16:25,502,513...25,710,852
G
Ifng
interferon gamma
IEP
mRNA,protein:increased expression:corneal
RGD
PMID:15832292
RGD:8157597
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Bmp4
bone morphogenetic protein 4
ISO
mRNA:increased expression:superior cervical ganglion
RGD
PMID:16420416
RGD:2289006
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:15153618
RGD:4891994
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
S100b
S100 protein, beta polypeptide, neural
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:22553604
RGD:7364851
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il1b
interleukin 1 beta
IEP
protein:increased expression:retina
RGD
PMID:9618720
RGD:7794723
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:cornea, neutrophil, macrophage (rat)
RGD
PMID:24194635
RGD:8552904
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Fgf2
fibroblast growth factor 2
IMP ISO
protein:increased expression:lens
RGD
PMID:15273655 PMID:15273655
RGD:8655664 , RGD:8655664
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Mir182
microRNA 182
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr 6:30,165,917...30,165,991
Ensembl chr 6:30,165,917...30,165,991
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr 6:30,169,667...30,169,736
Ensembl chr 6:30,169,667...30,169,736
G
Mir96
microRNA 96
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27208084
NCBI chr 6:30,169,445...30,169,550
Ensembl chr 6:30,169,445...30,169,550
G
Pparg
peroxisome proliferator activated receptor gamma
treatment
IMP
RGD
PMID:18658087
RGD:8552893
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Adcyap1
adenylate cyclase activating polypeptide 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:19427307
RGD:2325258
NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
G
Atf2
activating transcription factor 2
ISO
RGD
PMID:9813301
RGD:10047413
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Ccr3
C-C motif chemokine receptor 3
IMP
RGD
PMID:19922414
RGD:6892922
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
Cd59a
CD59a antigen
ISO
mRNA, protein:increased expression:facial VII nucleus
RGD
PMID:9846834
RGD:1600495
NCBI chr 2:103,926,177...103,945,755
Ensembl chr 2:103,926,146...103,945,699
G
Cd59b
CD59b antigen
ISO
mRNA, protein:increased expression:facial VII nucleus
RGD
PMID:9846834
RGD:1600495
NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534
G
Clu
clusterin
ISO
protein:increased expression:neuron,astrocyte
RGD
PMID:10800205
RGD:408418725
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Csf1
colony stimulating factor 1 (macrophage)
ISO
protein:increased expression:facial VII nerve, microglial cell
RGD
PMID:20831658
RGD:5131509
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Ctss
cathepsin S
IMP
RGD
PMID:17539023
RGD:5686912
NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
G
Gfra1
glial cell line derived neurotrophic factor family receptor alpha 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
G
Hgf
hepatocyte growth factor
treatment
ISO
RGD
PMID:21562589
RGD:8548634
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Mt3
metallothionein 3
treatment
ISO
RGD
PMID:14625437
RGD:9685806
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Ndufa5
NADH:ubiquinone oxidoreductase subunit A5
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:8875451
RGD:2302319
NCBI chr 6:24,518,661...24,527,689
Ensembl chr 6:24,518,665...24,528,012
G
Ret
ret proto-oncogene
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Acvr1b
activin A receptor, type 1B
ISO
RGD
PMID:9013782
RGD:151665480
NCBI chr15:101,071,953...101,111,565
Ensembl chr15:101,071,948...101,111,565
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Aif1
allograft inflammatory factor 1
ISO
RGD
PMID:9698327
RGD:704401
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Csnk2b
casein kinase 2, beta polypeptide
ISO
RGD
PMID:11068334
RGD:11565824
NCBI chr17:35,335,171...35,341,029
Ensembl chr17:35,335,172...35,341,029
G
Fgf2
fibroblast growth factor 2
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fgfr1
fibroblast growth factor receptor 1
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Gfra1
glial cell line derived neurotrophic factor family receptor alpha 1
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
G
Il1r1
interleukin 1 receptor, type I
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
G
Mcam
melanoma cell adhesion molecule
ISO
RGD
PMID:10076889
RGD:7364787
NCBI chr 9:44,045,958...44,054,024
Ensembl chr 9:44,045,766...44,054,024
G
Mme
membrane metallo endopeptidase
ISO
RGD
PMID:8201016
RGD:13801045
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Prkaca
protein kinase, cAMP dependent, catalytic, alpha
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr 8:84,699,607...84,723,073
Ensembl chr 8:84,699,622...84,723,072
G
Prkacb
protein kinase, cAMP dependent, catalytic, beta
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr 3:146,435,334...146,518,691
Ensembl chr 3:146,435,329...146,518,745
G
Ret
ret proto-oncogene
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Smad1
SMAD family member 1
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147
G
Smad2
SMAD family member 2
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
G
Smad3
SMAD family member 3
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Smad4
SMAD family member 4
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Smad7
SMAD family member 7
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:75,500,436...75,529,006
Ensembl chr18:75,500,600...75,529,006
G
Smad9
SMAD family member 9
ISO
mRNA:decreased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 3:54,662,873...54,709,162
Ensembl chr 3:54,663,003...54,708,678
G
Txnrd1
thioredoxin reductase 1
ISO
mRNA, protein:increased expression:neuron
RGD
PMID:19833109
RGD:5133729
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
G
Gp6
glycoprotein 6 platelet
exacerbates
IMP
RGD
PMID:21258336
RGD:401824683
NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743
G
Mdm2
transformed mouse 3T3 cell double minute 2
treatment
ISO
RGD
PMID:34334113
RGD:155882538
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Zeb2
zinc finger E-box binding homeobox 2
treatment
ISO
protein:increased expression:brain (rat)
RGD
PMID:34334113 PMID:34334113
RGD:155882538 , RGD:155882538
NCBI chr 2:44,873,523...45,007,378
Ensembl chr 2:44,873,644...45,007,407
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
ISO
mRNA:decreased expression:bone
RGD
PMID:19607804
RGD:5147852
NCBI chr10:17,598,452...17,601,422
Ensembl chr10:17,598,966...17,601,422
G
Ihh
Indian hedgehog
ISO
RGD
PMID:23992905
RGD:12911207
NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
ISO
mRNA:increased expression:motor neuron
RGD
PMID:21456016
RGD:5684341
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Adcy10
adenylate cyclase 10
ISO
protein:decreased expression:retina
RGD
PMID:22649251
RGD:329347828
NCBI chr 1:165,309,114...165,404,347
Ensembl chr 1:165,312,752...165,404,343
G
Adnp
activity-dependent neuroprotective protein
ISO
RGD
PMID:18414890
RGD:2312783
NCBI chr 2:168,022,885...168,049,032
Ensembl chr 2:168,022,906...168,049,032
G
Amigo3
adhesion molecule with Ig like domain 3
treatment
ISO
RGD
PMID:23613963
RGD:14390159
NCBI chr 9:107,930,358...107,932,900
Ensembl chr 9:107,930,358...107,932,900
G
Aqp4
aquaporin 4
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Aqp9
aquaporin 9
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
G
Arg2
arginase type II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30618589
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Atf2
activating transcription factor 2
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Bax
BCL2-associated X protein
ISO
mRNA:increased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
ISO
mRNA:decreased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bdnf
brain derived neurotrophic factor
treatment
ISO IDA
RGD
PMID:15140649 PMID:11050383 PMID:9520478
RGD:8655584 , RGD:8655586 , RGD:8655637
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
C3
complement component 3
ISO
mRNA:increased expression:optic nerve
RGD
PMID:14577867
RGD:5129542
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cdk2
cyclin dependent kinase 2
ISO
mRNA:increased expression:retina
RGD
PMID:16723461
RGD:2293567
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
G
Cfl1
cofilin 1, non-muscle
treatment
ISO
RGD
PMID:27443501
RGD:11568693
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Clu
clusterin
ISO
RGD
PMID:14577867
RGD:5129542
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Csf1r
colony stimulating factor 1 receptor
ISO
mRNA:increased expression:retina (rat)
RGD
PMID:20187850
RGD:151665810
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:20144610
RGD:11039471
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Ctsb
cathepsin B
ISO
protein:increased expression:retina (rat)
RGD
PMID:18775855
RGD:2315508
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Edn1
endothelin 1
ISO
protein:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Ednra
endothelin receptor type A
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
G
Ednrb
endothelin receptor type B
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr14:104,052,055...104,081,764
Ensembl chr14:104,052,061...104,081,838
G
Ep300
E1A binding protein p300
ISO
protein:decreased expression:retinal ganglion cell layer (rat) human gene in rat model
RGD
PMID:21705428 PMID:21705428
RGD:7349392 , RGD:7349392
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Fgf2
fibroblast growth factor 2
treatment
ISO
RGD
PMID:14664816
RGD:8554854
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:retina
RGD
PMID:33664770
RGD:329951020
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
Gdnf
glial cell line derived neurotrophic factor
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gfra1
glial cell line derived neurotrophic factor family receptor alpha 1
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
G
Gfra2
glial cell line derived neurotrophic factor family receptor alpha 2
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr14:71,127,547...71,217,280
Ensembl chr14:71,127,560...71,217,278
G
Hgf
hepatocyte growth factor
treatment
ISO
RGD
PMID:21443522
RGD:8548549
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Igf1r
insulin-like growth factor I receptor
ISO
protein: altered activity: eye protein:increased expression:retina:
RGD
PMID:19484445 PMID:23648097
RGD:5686431 , RGD:10046025
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Jun
jun proto-oncogene
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr 1:172,168,777...172,201,652
Ensembl chr 1:172,168,777...172,201,652
G
mt-Co1
cytochrome c oxidase I, mitochondrial
IEP
mRNA:increased expression:retina
RGD
PMID:12076086
RGD:8662362
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
G
Myrf
myelin regulatory factor
ISO
mRNA:decreased expression: oligodendrocyte
RGD
PMID:29915135
RGD:213230153
NCBI chr19:10,185,635...10,218,134
Ensembl chr19:10,185,636...10,218,112
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
ISO
RGD
PMID:28032230
RGD:13781885
NCBI chr12:32,870,334...32,903,368
Ensembl chr12:32,869,544...32,903,348
G
Ncam1
neural cell adhesion molecule 1
IMP
RGD
PMID:18757519
RGD:2326023
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
Nefm
neurofilament, medium polypeptide
ISO
RGD
PMID:8501527
RGD:9743936
NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295
G
Neo1
neogenin
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr 9:58,781,962...58,943,926
Ensembl chr 9:58,781,970...58,943,724
G
Ngf
nerve growth factor
ISO
protein:increased expression:retina
RGD
PMID:28067793
RGD:402463954
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
treatment
ISO
RGD
PMID:20357199 PMID:34245756
RGD:5684908 , RGD:597015764
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Pawr
PRKC, apoptosis, WT1, regulator
ISO
mRNA:increased expression:retina:
RGD
PMID:12836167
RGD:1299297
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pax6
paired box 6
ISO
protein:increased expression:retina (rat)
RGD
PMID:23297010
RGD:8552379
NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
protein:decreased expression:nerve fiber:
RGD
PMID:9893812
RGD:10449496
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pecam1
platelet/endothelial cell adhesion molecule 1
ISO
protein:increased expression:optic nerve (rat)
RGD
PMID:22336118
RGD:6767293
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Plau
plasminogen activator, urokinase
ISO
mRNA:increased expression:optic nerve (rat)
RGD
PMID:20798533
RGD:6483802
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
ISO
protein:increased expression:retina (rat)
RGD
PMID:15555919
RGD:9835027
NCBI chr 7:46,727,543...46,783,774
Ensembl chr 7:46,727,543...46,783,432
G
Rhoa
ras homolog family member A
ISO
protein:increased expression, altered localization:retina
RGD
PMID:17534117
RGD:1642826
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Snw1
SNW domain containing 1
ISO
protein:increased expression:retina (rat)
RGD
PMID:25074585
RGD:11035254
NCBI chr12:87,496,680...87,519,069
Ensembl chr12:87,495,845...87,519,044
G
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:19661221
RGD:597538516
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
IEP
protein:increased expression:optic nerve
RGD
PMID:23103505
RGD:7794777
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
ISO IMP
RGD
PMID:18552980 PMID:14697498
RGD:7794683 , RGD:8661743
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tradd
TNFRSF1A-associated via death domain
ISO
protein:increased expression: retina
RGD
PMID:18552980
RGD:7794683
NCBI chr 8:105,985,207...105,991,226
Ensembl chr 8:105,984,918...105,991,241
G
Ybx3
Y box protein 3
ISO
mRNA:increased expression:retinal ganglion cell
RGD
PMID:11750989
RGD:2311250
NCBI chr 6:131,341,821...131,365,413
Ensembl chr 6:131,341,818...131,365,439
G
Fgf2
fibroblast growth factor 2
IEP
mRNA:increased expression:retina
RGD
PMID:9268592
RGD:8655567
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Neo1
neogenin
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr 9:58,781,962...58,943,926
Ensembl chr 9:58,781,970...58,943,724
G
Rgma
repulsive guidance molecule family member A
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr 7:73,025,268...73,069,647
Ensembl chr 7:73,025,257...73,069,647
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
protein:increased expression,increased activity:cerebral cortex:
RGD
PMID:16672190
RGD:9685448
NCBI chr19:40,600,810...40,730,046
Ensembl chr19:40,600,810...40,730,046
G
Fgfr1
fibroblast growth factor receptor 1
ISO
mRNA,protein:increased expression:astrocyte,macrophage,neutrophil:
RGD
PMID:11168551
RGD:10402049
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Gfap
glial fibrillary acidic protein
IMP
RGD
PMID:10225952
RGD:6480471
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
protein:increased expression:neuron:
RGD
PMID:7526956
RGD:10449485
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Vim
vimentin
IMP
RGD
PMID:10225952
RGD:6480471
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Trh
thyrotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8690305
NCBI chr 6:92,219,042...92,221,631
Ensembl chr 6:92,219,042...92,221,631
G
Bmp4
bone morphogenetic protein 4
treatment
ISO
RGD
PMID:16332232
RGD:8699514
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
G
Igf1
insulin-like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Plat
plasminogen activator, tissue
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1899364
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Adam10
a disintegrin and metallopeptidase domain 10
ISO
RGD
PMID:22489706
RGD:13703033
NCBI chr 9:70,586,133...70,687,511
Ensembl chr 9:70,586,279...70,687,511
G
Ahr
aryl-hydrocarbon receptor
ISO
protein:increased expression:T cell, neuron, brain cortex, hippocampus
RGD
PMID:27506546
RGD:405878081
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
App
amyloid beta precursor protein
treatment
ISO
RGD
PMID:29320530
RGD:13782048
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Bad
BCL2-associated agonist of cell death
treatment
ISO
RGD
PMID:24582457
RGD:13782254
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bdnf
brain derived neurotrophic factor
ISO
mRNA:increased expression:CA3 field of hippocampus, dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Bid
BH3 interacting domain death agonist
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:632018 , RGD:5509821
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Capn1
calpain 1
severity
ISO
protein:increased expression:cytosol, plasma membrane
RGD
PMID:9469158 PMID:15307896
RGD:13792664 , RGD:5509821
NCBI chr19:6,038,573...6,065,855
Ensembl chr19:6,038,573...6,065,927
G
Capn2
calpain 2
severity
ISO
RGD
PMID:9469158 PMID:15307896
RGD:13792664 , RGD:5509821
NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
G
Casp3
caspase 3
severity
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125 PMID:15307896
RGD:329961568 , RGD:5509821
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:632018 , RGD:5509821
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:632018 , RGD:5509821
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Ccng1
cyclin G1
treatment
ISO
RGD
PMID:24398934 PMID:18612315
RGD:151356934 , RGD:151356935
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
G
Cd163
CD163 antigen
ISO
protein:increased expression:brain, macrophage (rat)
RGD
PMID:22583855
RGD:127285798
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
G
Cd8a
CD8 subunit alpha
IEP
mRNA:increased expression:brain (mouse)
RGD
PMID:31383034
RGD:124715446
NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157
G
Cit
citron
ISO
mRNA:decreased expression:cerebral cortex��(rat)
RGD
PMID:12503083
RGD:2317873
NCBI chr 5:115,983,284...116,147,012
Ensembl chr 5:115,983,337...116,147,006
G
Ctnnb1
catenin beta 1
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment
IEP
RGD
PMID:26435412
RGD:27095897
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
treatment
ISO
RGD
PMID:26068867
RGD:401901590
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Drd1
dopamine receptor D1
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
G
Drd2
dopamine receptor D2
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
Fubp1
far upstream element (FUSE) binding protein 1
ISO
RGD
PMID:23797733
RGD:13673879
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
G
Gnal
guanine nucleotide binding protein, alpha stimulating, olfactory type
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr18:67,221,369...67,359,863
Ensembl chr18:67,221,287...67,359,863
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
ISO
protein:increased phosphorylation:central amygdaloid nucleus (rat)
RGD
PMID:30638118
RGD:405101698
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Itgb1
integrin beta 1 (fibronectin receptor beta)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
G
Lama1
laminin, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr17:68,004,129...68,129,640
Ensembl chr17:68,004,254...68,129,642
G
Lamp2
lysosomal-associated membrane protein 2
ISO
protein:increased expression:hippocampus:
RGD
PMID:28365875
RGD:13703062
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
G
Lcn2
lipocalin 2
ISO
RGD
PMID:31539545
RGD:126781751
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Mapt
microtubule-associated protein tau
treatment
ISO
RGD
PMID:28412141 PMID:25771151 PMID:26484783 PMID:26729399
RGD:13800902 , RGD:13800917 , RGD:13800912 , RGD:13800909
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase subunit
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 3:123,161,944...123,179,639
Ensembl chr 3:123,161,946...123,179,757
G
Mir155
microRNA 155
IMP
RGD
PMID:28804446
RGD:25314324
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Ncstn
nicastrin
IEP
RGD
PMID:18240300
RGD:13801189
NCBI chr 1:171,893,580...171,910,356
Ensembl chr 1:171,893,580...171,910,362
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
protein:increased expression:brain:
RGD
PMID:30855558
RGD:26884463
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Ngf
nerve growth factor
treatment
ISO
RGD
PMID:26285082
RGD:402463964
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nmnat1
nicotinamide nucleotide adenylyltransferase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr 4:149,552,026...149,569,667
Ensembl chr 4:149,552,029...149,569,659
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nox1
NADPH oxidase 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
protein:increased phosphorylation:amygdala mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:30638118 PMID:36637480
RGD:405101698 , RGD:408364984
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
ISO
mRNA:increased expression:dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Ocln
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
G
Parp1
poly (ADP-ribose) polymerase family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829224 PMID:28642177
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pde10a
phosphodiesterase 10A
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr17:8,742,719...9,205,480
Ensembl chr17:8,744,204...9,205,480
G
Pdyn
prodynorphin
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12626770
RGD:633616
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Phactr1
phosphatase and actin regulator 1
treatment
IMP
RGD
PMID:36571365
RGD:401901253
NCBI chr13:42,833,909...43,292,002
Ensembl chr13:42,834,099...43,292,002
G
Ppp3r1
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I)
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr11:17,109,298...17,150,380
Ensembl chr11:17,109,263...17,150,375
G
Ppp3r2
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II)
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr 4:49,678,747...49,681,983
Ensembl chr 4:49,678,747...49,682,024
G
Psen1
presenilin 1
IEP
RGD
PMID:18240300
RGD:13801189
NCBI chr12:83,734,926...83,781,869
Ensembl chr12:83,734,926...83,781,973
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593 PMID:28642177
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Sox2
SRY (sex determining region Y)-box 2
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Tgfb1
transforming growth factor, beta 1
treatment
ISO
RGD
PMID:28433746
RGD:14995478
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trp53
transformation related protein 53
treatment
ISO
RGD
PMID:27553877
RGD:14995939
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ube4b
ubiquitination factor E4B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr 4:149,412,873...149,512,618
Ensembl chr 4:149,412,873...149,511,206
G
Wnt3a
wingless-type MMTV integration site family, member 3A
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20370756
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Abcc8
ATP-binding cassette, sub-family C member 8
treatment
ISO
RGD
PMID:18854840
RGD:2325137
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
G
Trp53
transformation related protein 53
ISO
RGD
PMID:22977862
RGD:8547771
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Adrb2
adrenergic receptor, beta 2
ISO
mRNA:increased expression:Vestibulocochlear nerve:
RGD
PMID:22178544
RGD:8548530
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all